First results from INFINITY – A Registry on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology in Routine Clinical Practice 5. November 2020 U Martens, M Reiser, S Schirrmacher-Memmel, L Sellmann, T Decker, A Schneeweiss, M Schuler, F Bengsch, C Vannier, K Potthoff, N Marschner, B Kasenda, 2020 Oncol Res Treat. 2020;43(suppl 4)(247):251 https://www.iomedico.com/wp-content/uploads/2020/11/Martens_INFINITY_DGHO2020.mp4 Prophylaxis of chemotherapy-induced neutropenia with Lipegfilgrastim in patients with SCLC: final results from the non-interventional study NADIR Losem C, Maintz C, Schulz H, Lück A, Geßner C, Grebhardt S, et al. Oncol Res Treat. 2020;43(suppl 4)(200):328 https://www.iomedico.com/wp-content/uploads/2020/11/Potthoff_NADIR_DGHO2020.mp4… Weiterlesen Everolimus after failure of one prior VEGF‐targeted therapy in metastatic renal cell carcinoma: Final results of the MARC‐2 trial Staehler M, Stöckle M, Christoph D C, Stenzl A, Potthoff K, Grimm M O, Klein D, Harde J, Brüning F, Goebell P J, Augustin M,… Weiterlesen